|
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
|
12/30/20
|
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
|
PDF
|
|
Bausch Health To Reduce Debt By $275 Million
|
12/29/20
|
Bausch Health To Reduce Debt By $275 Million
|
PDF
|
|
Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
|
11/24/20
|
Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
|
PDF
|
|
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes
|
11/18/20
|
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes
|
PDF
|
|
Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes
|
11/18/20
|
Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes
|
PDF
|
|
Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride
|
11/16/20
|
Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride
|
PDF
|
|
Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program
|
11/12/20
|
Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program
|
PDF
|
|
Salix To Present Data At AASLD's The Liver Meeting Digital Experience
|
11/11/20
|
Salix To Present Data At AASLD's The Liver Meeting Digital Experience
|
PDF
|
|
Bausch Health Announces Participation In Upcoming Investor Conferences
|
11/10/20
|
Bausch Health Announces Participation In Upcoming Investor Conferences
|
PDF
|
|
Bausch Health Companies Inc. Announces Third-Quarter 2020 Results
|
11/03/20
|
Bausch Health Companies Inc. Announces Third-Quarter 2020 Results
|
pdf
|
|
Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease
|
10/29/20
|
Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease
|
PDF
|
|
Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations
|
10/29/20
|
Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations
|
PDF
|
|
Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses
|
10/27/20
|
Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses
|
PDF
|
|
Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference
|
10/26/20
|
Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference
|
PDF
|
|
Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting
|
10/22/20
|
Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting
|
PDF
|
|
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens
|
10/15/20
|
Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens
|
PDF
|
|
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12
|
10/12/20
|
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12
|
PDF
|
|
Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020
|
10/08/20
|
Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020
|
PDF
|
|
Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery
|
10/08/20
|
Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery
|
PDF
|
|
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented On Bausch + Lomb Infuse™ Silicone Hydrogel Daily Disposable Contact Lenses During The American Academy Of Optometry Annual Meeting
|
10/06/20
|
Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented On Bausch + Lomb Infuse™ Silicone Hydrogel Daily Disposable Contact Lenses During The American Academy Of Optometry Annual Meeting
|
PDF
|
|
Salix Supports Liver Awareness Month With New Educational Initiatives
|
10/05/20
|
Salix Supports Liver Awareness Month With New Educational Initiatives
|
PDF
|
|
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List
|
10/01/20
|
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List
|
PDF
|
|
FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%
|
09/25/20
|
FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%
|
PDF
|
|
Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries
|
09/24/20
|
Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries
|
PDF
|
|
Bausch Health Releases Annual Corporate Social Responsibility Report
|
09/23/20
|
Bausch Health Releases Annual Corporate Social Responsibility Report
|
PDF
|
|
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
|
09/22/20
|
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
|
PDF
|
|
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
|
09/21/20
|
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
|
PDF
|
|
Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference
|
09/16/20
|
Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference
|
PDF
|
|
Bausch Foundation Releases Inaugural Activity Report
|
09/10/20
|
Bausch Foundation Releases Inaugural Activity Report
|
PDF
|
|
Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference
|
09/09/20
|
Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference
|
PDF
|
|
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
|
08/31/20
|
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
|
PDF
|
|
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses
|
08/18/20
|
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses
|
PDF
|
|
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
|
08/17/20
|
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
|
PDF
|
|
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses
|
08/11/20
|
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses
|
PDF
|
|
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company
|
08/06/20
|
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company
|
PDF
|
|
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results
|
08/06/20
|
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results
|
pdf
|
|
Bausch Health Resolves Canadian Securities Class Action
|
08/05/20
|
Bausch Health Resolves Canadian Securities Class Action
|
PDF
|
|
Bausch Health Resolves Legacy SEC Investigation
|
07/31/20
|
Bausch Health Resolves Legacy SEC Investigation
|
PDF
|
|
Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients
|
07/28/20
|
Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients
|
PDF
|
|
Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6
|
07/23/20
|
Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6
|
PDF
|
|
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States
|
06/23/20
|
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States
|
PDF
|
|
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China
|
06/17/20
|
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China
|
PDF
|
|
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference
|
06/16/20
|
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference
|
PDF
|
|
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients
|
06/15/20
|
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients
|
PDF
|
|
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses
|
06/04/20
|
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses
|
PDF
|
|
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses
|
05/27/20
|
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses
|
PDF
|
|
Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference
|
05/21/20
|
Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference
|
PDF
|
|
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization
|
05/11/20
|
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization
|
PDF
|
|
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes
|
05/11/20
|
Bausch Health Announces Launch of Private Offering of Senior Notes and Conditional Redemption of Existing Senior Secured Notes
|
PDF
|
|
Bausch Health Companies Inc. Announces First-Quarter 2020 Results
|
05/07/20
|
Bausch Health Companies Inc. Announces First-Quarter 2020 Results
|
pdf
|
|
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
|
05/06/20
|
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
|
PDF
|
|
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference
|
04/30/20
|
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference
|
PDF
|
|
Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting
|
04/30/20
|
Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting
|
PDF
|
|
Bausch Health Announces 2020 Annual Meeting Of Shareholder Results
|
04/29/20
|
Bausch Health Announces 2020 Annual Meeting Of Shareholder Results
|
PDF
|
|
FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
|
04/29/20
|
FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
|
PDF
|
|
Bausch Health Issues Form 8-K For 2020 Annual Meeting Of Shareholders Presentation
|
04/28/20
|
Bausch Health Issues Form 8-K For 2020 Annual Meeting Of Shareholders Presentation
|
PDF
|
|
Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7
|
04/23/20
|
Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7
|
PDF
|
|
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology
|
04/14/20
|
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology
|
PDF
|
|
Bausch Health Initiates VIRAZOLE® (Ribavirin for Inhalation Solution, USP) Clinical Study in Patients with COVID-19
|
04/13/20
|
Bausch Health Initiates VIRAZOLE® (Ribavirin for Inhalation Solution, USP) Clinical Study in Patients with COVID-19
|
PDF
|
|
Bausch Health Companies Inc. Will Hold Virtual Annual Meeting Of Shareholders On April 28
|
04/02/20
|
Bausch Health Companies Inc. Will Hold Virtual Annual Meeting Of Shareholders On April 28
|
PDF
|
|
Bausch Health Announces Favorable Topline Results From Study Evaluating Investigative Formulation of Rifaximin SSD IR to Treat Overt Hepatic Encephalopathy
|
03/31/20
|
Bausch Health Announces Favorable Topline Results From Study Evaluating Investigative Formulation of Rifaximin SSD IR to Treat Overt Hepatic Encephalopathy
|
PDF
|
|
Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic
|
03/24/20
|
Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic
|
PDF
|
|
Bausch Health To Reduce Debt By Approximately $100 Million Using Cash Generated From Operations
|
03/13/20
|
Bausch Health To Reduce Debt By Approximately $100 Million Using Cash Generated From Operations
|
PDF
|
|
Bausch Health Announces It Will No Longer Pursue Proposed Refinancing Transaction And Also Announces Cancellation Of Previously Delivered Notice Of Conditional Redemption
|
03/02/20
|
Bausch Health Announces It Will No Longer Pursue Proposed Refinancing Transaction And Also Announces Cancellation Of Previously Delivered Notice Of Conditional Redemption
|
PDF
|
|
Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of Existing Senior Secured Notes
|
02/19/20
|
Bausch Health Announces It Is Seeking A Refinancing Amendment To Its Existing Credit Agreement And Conditional Redemption Of Existing Senior Secured Notes
|
PDF
|
|
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance
|
02/19/20
|
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance
|
pdf
|
|
Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program
|
02/18/20
|
Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program
|
PDF
|
|
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
|
02/12/20
|
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
|
PDF
|
|
Bausch Health Announces Participation In Upcoming Investor Conferences
|
02/04/20
|
Bausch Health Announces Participation In Upcoming Investor Conferences
|
PDF
|
|
Bausch + Lomb And Prevent Blindness Join Together To Raise Awareness And Provide Educational Resources For February's Age-Related Macular Degeneration Awareness Month
|
02/03/20
|
Bausch + Lomb And Prevent Blindness Join Together To Raise Awareness And Provide Educational Resources For February's Age-Related Macular Degeneration Awareness Month
|
PDF
|
|
Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Program
|
02/03/20
|
Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Program
|
PDF
|
|
Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology
|
01/28/20
|
Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology
|
PDF
|
|
Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19
|
01/16/20
|
Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19
|
PDF
|
|
Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference
|
01/13/20
|
Bausch Health Publishes Company Update for the 38th Annual J.P. Morgan Healthcare Conference
|
PDF
|
|
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO™ (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD)
|
01/13/20
|
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO™ (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD)
|
PDF
|
|
Bausch + Lomb Launches Expanded Parameters for Biotrue® ONEday for Astigmatism Daily Disposable Contact Lenses
|
01/06/20
|
Bausch + Lomb Launches Expanded Parameters for Biotrue® ONEday for Astigmatism Daily Disposable Contact Lenses
|
PDF
|
|
Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference
|
01/06/20
|
Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference
|
PDF
|
